Get started
Author

Hannah Goldschmid

Observed names: Goldschmid, Hannah, H Goldschmid, H. Goldschmid
OpenAlex ID: A5114081448
Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD)
2022 · E. Rempel, K. Kluck, et al. · npj Precision Oncology · 98
PDF
Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing
2022 · Olaf Neumann, Timothy C. Burn, et al. · British Journal of Cancer · 88
PDF
The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinoma
2021 · M. Kirchner, K. Kluck, et al. · ESMO Open · 39
Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients
2023 · Michael Menzel, Stephan Ossowski, et al. · npj Precision Oncology · 36
PDF
Assigning evidence to actionability: An introduction to variant interpretation in precision cancer medicine
2021 · Peter Horak, Jonas Leichsenring, et al. · Genes Chromosomes and Cancer · 34
PDF
High fat feeding affects the number of GPR120 cells and enteroendocrine cells in the mouse stomach
2015 · Patricia Widmayer, Hannah Goldschmid, et al. · Frontiers in Physiology · 29
PDF
Structure and content of the EU-IVDR
2023 · Andy Kahles, Hannah Goldschmid, et al. · Die Pathologie · 28
PDF
Targeting rare and non-canonical driver variants in NSCLC – An uncharted clinical field
2021 · Anna-Lena Volckmar, Petros Christopoulos, et al. · Lung Cancer · 18
Regulation (EU) 2017/746 (IVDR): practical implementation of annex I in pathology
2023 · Andy Kahles, Hannah Goldschmid, et al. · Die Pathologie · 17
PDF
Regulation of laboratory-developed tests and in-house in vitro diagnostic medical devices in the United States and the European Union—a comparative overview
2025 · A. Kahles, A.-L. Volckmar, et al. · ESMO Open · 14
PDF
First proficiency testing for NGS ‐based and combined NGS ‐ and FISH ‐based detection of FGFR2 fusions in intrahepatic cholangiocarcinoma
2023 · Olaf Neumann, Ulrich Lehmann, et al. · The Journal of Pathology Clinical Research · 14
PDF
Benchmarking whole exome sequencing in the German network for personalized medicine
2024 · Michael Menzel, Mihaela Martis-Thiele, et al. · European Journal of Cancer · 13
PDF
Spatial profiling of the microenvironment reveals low intratumoral heterogeneity and STK11-associated immune evasion in therapy-naïve lung adenocarcinomas
2023 · Hannah Goldschmid, Klaus Kluck, et al. · Lung Cancer · 12
Struktur und Inhalt der EU-IVDR
2022 · Andy Kahles, Hannah Goldschmid, et al. · Die Pathologie · 11
PDF
Clinical Implementation of a High-Throughput Automated Comprehensive Genomic Profiling Test
2024 · Markus Ball, Eva Romanovsky, et al. · Journal of Molecular Diagnostics · 7
PDF
Die Verordnung (EU) 2017/746 (IVDR) in der Praxis: Umsetzung von Anhang I in der Pathologie
2023 · Andy Kahles, Hannah Goldschmid, et al. · Die Pathologie · 7
PDF
Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR‐mutated lung cancer treated with the first‐/second‐generation tyrosine kinase inhibitors
2024 · Michael Menzel, Martina Kirchner, et al. · The Journal of Pathology Clinical Research · 4
PDF
Diagnostic whole transcriptome sequencing in a series of 1233 FFPE solid tumor samples
2026 · Markus Ball, Susanne Beck, et al. · British Journal of Cancer · 1
PDF
Leveraging Off-Target Reads in Panel Sequencing for Homologous Recombination Repair Deficiency Screening in Tumor
2024 · Markus Ball, Iordanis Ourailidis, et al. · Journal of Molecular Diagnostics · 1
PDF
Correction: Diagnostic whole transcriptome sequencing in a series of 1233 FFPE solid tumor samples
2026 · Markus Ball, Susanne Beck, et al. · British Journal of Cancer
PDF
Die Pathologie im Rahmen des europäischen und nationalen Medizinprodukterechts: Betrieb, Anwendung und Eigenherstellung von In-vitro-Diagnostika
2024 · Kahles, Andy, Goldschmid, Hannah, et al. · PubMed Central
131P Benchmarking whole exome sequencing in the German network for personalized medicine
2024 · M. Menzel, M. Martis-Thiele, et al. · ESMO Open
PDF
B034 A Gene Expression—Based Proliferation Index as Independent Prognostic Factor in Multiple Myeloma
2009 · D Hose, T Rème, et al. · Clinical Lymphoma & Myeloma
Works count: 25
Citation count: 471
H-index: 12
I10-index: 14
Year
Topic
Type